Next Article in Journal
Community-Based Pharmacy Practice Innovation and the Role of the Community-Based Pharmacist Practitioner in the United States
Previous Article in Journal
Tetracycline Allergy
Previous Article in Special Issue
Pharmacy Technician Review of Oral Nutritional Supplements (ONS) within Care Homes
Article Menu

Export Article

Open AccessArticle

Deprescribing of Medicines in Care Homes—A Five-Year Evaluation of Primary Care Pharmacist Practices

1
NHS Somerset Clinical Commissioning Group, Yeovil BA22 8HR, UK
2
Department of Applied Psychology, Cardiff School of Sport and Health Sciences, Cardiff Metropolitan University, Llandaf Campus, Cardiff CF5 2YB, UK
*
Author to whom correspondence should be addressed.
Pharmacy 2019, 7(3), 105; https://doi.org/10.3390/pharmacy7030105
Received: 6 May 2019 / Revised: 24 July 2019 / Accepted: 1 August 2019 / Published: 3 August 2019
(This article belongs to the Special Issue Optimising Medicines in Care Homes)
  |  
PDF [499 KB, uploaded 3 August 2019]
  |  

Abstract

(1) Background: This project evaluates the outcomes of a novel pharmacy-led model of deprescribing unnecessary medications for care home patients. A feasibility study was conducted in 2015 to explore exposure to inappropriate polypharmacy in patients residing in care homes over a one-year timescale. The aim of this study was to present the results of this ongoing service evaluation over a five-year period. (2) Methods: Data collection and risk assessment tools developed during the feasibility study were used to measure the prevalence, nature, and impact of deprescribing interventions by primary care pharmacists over a five-year period. A random sample of approximately 5% of safety interventions were screened twice yearly by the pharmacist leads as part of standard practice. (3) Results: Over a period of five years there were 23,955 interventions (mean 2.3 per patient) reported from the 10,405 patient reviews undertaken. Deprescribing accounted for 53% of total estimated financial drug savings, equating to £431,493; and 16.1% of all interventions were related to safety. (4) Conclusions: Medication reviews in care homes, undertaken by primary care pharmacists who are linked to GP practices, generate a wide range of interventions commonly involving deprescribing, which contributes significantly to the continuous optimisation of the prescribing and monitoring of medicines. View Full-Text
Keywords: care homes; deprescribing; pharmacists care homes; deprescribing; pharmacists
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material

SciFeed

Share & Cite This Article

MDPI and ACS Style

Alves, A.; Green, S.; James, D.H. Deprescribing of Medicines in Care Homes—A Five-Year Evaluation of Primary Care Pharmacist Practices. Pharmacy 2019, 7, 105.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Pharmacy EISSN 2226-4787 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top